Wind Energy Investments: Eurofarma Partners With Omega Energia to Participate in Assuruá 4 Wind Farm in Bahia State

Investments in the Participation of the Assuruá 4 Wind Farm Confirm Eurofarma’s Pursuit of Implementing Renewable Energies in Its Operations. The Contract with Omega Energia Provides for the Supply of Wind Energy for Internal Consumption.

The giant of Brazil, Eurofarma, is seeking more sustainability and environmental commitment in its operations over the next few years. The company has established a partnership with Omega Energia to participate in the Assuruá 4 wind farm, located in the state of Bahia. The agreement with the energy company provides for the supply of 100% of the pharmaceutical company’s operations with wind energy over the coming years.

Assuruá 4 Wind Farm Will Be Responsible for Supplying Wind Energy to Eurofarma After Partnership with Omega Energia

Omega Energia is increasingly expanding its renewable energy projects and bringing more sustainability to the national industrial sector in 2022.

Eurofarma has just established a partnership with the energy company for a stake in the Assuruá 4 wind farm, located in the state of Bahia.

The partnership will take effect from 2024, possibly being advanced, ensuring that 100% of Eurofarma’s energy consumption is supplied with renewable energy and the decarbonization of 260,000 tons of carbon dioxide (CO2) in the atmosphere by 2038.

Although still in the early stages, the partnership with Omega Energia may bring significant results regarding market growth for the energy company and cost reductions for the pharmaceutical company.

However, the agreement for the supply of wind energy from Assuruá 4 is still subject to modifications or revocations by the Administrative Council for Economic Defense — CADE and financial institutions.

Maria del Pilar Muñoz, Vice President of Sustainability and New Business at Eurofarma, highlights: “We were greatly challenged to find a solution that would allow us to achieve the ambitious goal of having our energy matrix 100% renewable in a short period of time.”

The executive also emphasized the enthusiasm for the new wind energy project: “We rely on the support of external consulting and the dedication of a multidisciplinary team. We are excited about the inauguration of the new wind farm. The green economy is already a reality, and we want to harness Brazil’s potential by increasingly investing in solutions like this.”

Eurofarma Is a National Reference in Sustainability and the Wind Energy Project from Omega Energia Will Contribute to Maintaining This Status in the Brazilian Market

Omega Energia celebrated the new partnership with Eurofarma for investments in the Assuruá 4 wind farm, highlighting that they took another important step in executing our environmental plan.

Meanwhile, Eurofarma, the only pharmaceutical company to win the Guia Exame de Sustentabilidade five times, in 2013, 2015, 2018, 2019, and 2022, continues to invest in renewable energy solutions in 2023.

Moreover, the partnership with a leading health company demonstrates total alignment with the goals and principles of Omega Energia, which was born sustainable.

Thus, the wind energy project is yet another initiative that proves the pharmaceutical company’s commitment to sustainability in Brazil.

Learn More About Omega Energia

Omega Energia has become the largest Brazilian company for generation from renewable sources and today produces energy capable of supplying 3 million and 800 thousand households.

Its mission is to empower companies and individuals through clean, affordable, and simple energy, ensuring cost reduction and contributing to a low-carbon economy.